Updated Jun 2, 2026
Selected portfolio
Experimental
Top 1 · Monthly · Equal
Rank #3
Risk
Experimental
Risk
Experimental
Stocks included
Top 1
Stocks included
Top 1
Rebalance
Monthly
Rebalance
Monthly
Weighting
Equal weight
Weighting
Equal weight
Key metrics
Since Feb 17, 2026
- $16,192 (+61.9%)
Portfolio value
- +50.7%
Performance vs S&P 500
- 3.81
Sharpe ratio
- +434.6%
CAGR
- -12.0%
Max drawdown
What you are looking at
Starting capital: $10,000 simulated. Disclaimer
| # | Stock | Value | Cost basis |
|---|---|---|---|
Returns
Risk
Consistency
Want the methodology notes?
See the full methodology, portfolio-ranking rules, and scientific grounding.
Not investment advice. Past performance does not guarantee future results. Full disclaimer